Beyond the membrane: Exploring non-viral methods for mitochondrial gene delivery.

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Mitochondrial disorders arise from mutations in mitochondrial DNA (mtDNA), presenting complex therapeutic challenges.
• Current gene therapy using viral vectors faces limitations like immunogenicity and insertional mutagenesis.

Purpose of the Study:

• To review non-viral methods for mitochondrial gene delivery as an alternative to viral vectors.
• To elucidate the mechanisms, advantages, and applications of these novel approaches in treating mitochondrial diseases.

Main Methods:

• Focus on lipid-based nanoparticles, polymer-based vectors, and mitochondrial-targeted peptides.
• Analysis of case studies demonstrating the application of these non-viral delivery systems.

Main Results:

• Non-viral vectors demonstrate reduced immunogenicity and enhanced safety profiles.
• These methods show potential for correcting pathogenic mtDNA mutations and mitigating disease phenotypes.

Conclusions:

• Non-viral gene delivery systems offer a promising avenue for treating mitochondrial disorders.
• Further research is needed to optimize delivery efficiency, specificity, and long-term expression for clinical translation.